RU2014140177A - Фармацевтические антиретровирусные композиции - Google Patents

Фармацевтические антиретровирусные композиции Download PDF

Info

Publication number
RU2014140177A
RU2014140177A RU2014140177A RU2014140177A RU2014140177A RU 2014140177 A RU2014140177 A RU 2014140177A RU 2014140177 A RU2014140177 A RU 2014140177A RU 2014140177 A RU2014140177 A RU 2014140177A RU 2014140177 A RU2014140177 A RU 2014140177A
Authority
RU
Russia
Prior art keywords
composition according
nevirapine
pharmaceutical
pharmaceutical antiretroviral
festinavir
Prior art date
Application number
RU2014140177A
Other languages
English (en)
Russian (ru)
Inventor
Джина Малхотра
Шринивас Мадхукар ПУРАНДАРЕ
Original Assignee
Сипла Лимитед
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Сипла Лимитед filed Critical Сипла Лимитед
Publication of RU2014140177A publication Critical patent/RU2014140177A/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
RU2014140177A 2012-03-05 2013-03-05 Фармацевтические антиретровирусные композиции RU2014140177A (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN583/MUM/2012 2012-03-05
IN583MU2012 2012-03-05
PCT/GB2013/000092 WO2013132208A1 (en) 2012-03-05 2013-03-05 Pharmaceutical antiretroviral combinations comprising lamivudine, festinavir and nevirapine

Publications (1)

Publication Number Publication Date
RU2014140177A true RU2014140177A (ru) 2016-04-27

Family

ID=47884388

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2014140177A RU2014140177A (ru) 2012-03-05 2013-03-05 Фармацевтические антиретровирусные композиции

Country Status (13)

Country Link
US (1) US20150104511A1 (2)
EP (1) EP2822560A1 (2)
JP (1) JP2015509524A (2)
KR (1) KR20140138837A (2)
CN (1) CN104203244A (2)
AU (1) AU2013229274A1 (2)
BR (1) BR112014021927A2 (2)
CA (1) CA2866133A1 (2)
IN (1) IN2014MN01907A (2)
MX (1) MX2014010337A (2)
RU (1) RU2014140177A (2)
WO (1) WO2013132208A1 (2)
ZA (1) ZA201406495B (2)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014124092A2 (en) * 2013-02-07 2014-08-14 Tobira Therapeutics, Inc. Lamivudine salts
EP3153157A1 (en) 2015-10-09 2017-04-12 Teva Pharmaceutical Works Private Limited Company Pharmaceutical composition for prolonged release of nevirapine
AR112412A1 (es) 2017-08-17 2019-10-23 Gilead Sciences Inc Formas de sal de colina de un inhibidor de la cápside del vih
TWI687415B (zh) 2017-08-17 2020-03-11 美商基利科學股份有限公司 Hiv蛋白質膜抑制劑之固體形式
CN111836805B (zh) 2018-02-15 2023-07-14 吉利德科学公司 吡啶衍生物及其用于治疗hiv感染的用途
US11944611B2 (en) * 2018-07-16 2024-04-02 Gilead Sciences, Inc. Capsid inhibitors for the treatment of HIV
MX2021008751A (es) 2019-01-25 2021-11-12 Univ Brown Composiciones y metodos para tratar, prevenir o revertir la inflamacion y los trastornos asociados a la edad.
JP7520162B2 (ja) 2020-06-25 2024-07-22 ギリアード サイエンシーズ， インコーポレイテッド Ｈｉｖの治療のためのカプシド阻害剤
JP7765637B2 (ja) 2021-12-03 2025-11-06 ギリアード サイエンシーズ， インコーポレイテッド Ｈｉｖウイルス感染症のための治療化合物
PT4440702T (pt) 2021-12-03 2025-08-13 Gilead Sciences Inc Compostos terapêuticos para a infecção pelo vírus do hiv
WO2023102523A1 (en) 2021-12-03 2023-06-08 Gilead Sciences, Inc. Therapeutic compounds for hiv virus infection

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69206876T3 (de) 1991-05-16 2004-08-12 Glaxo Group Ltd., Greenford Nukleosidanalogen enthaltende Antiviren-Zubereitungen
GB9622681D0 (en) 1996-10-31 1997-01-08 Glaxo Group Ltd Pharmaceutical compositions
PT1035834E (pt) * 1997-12-05 2002-09-30 Alza Corp Forma de dosagem osmotica que compreende primeiro e segundo revestimentos
DE69916425T2 (de) 1998-01-16 2005-05-19 Medivir Ab Antivirale mittel
GB9809213D0 (en) 1998-04-29 1998-07-01 Glaxo Group Ltd Pharmaceutical compositions
EP1610797A1 (en) 2003-03-27 2006-01-04 Boehringer Ingelheim International GmbH Antiviral combination of nevirapine and a further antiretroviral compound
KR20080053317A (ko) * 2005-08-31 2008-06-12 씨아이피엘에이 엘티디. 라미부딘, 스타부딘 및 네비라핀을 포함하는 약학적 조합물
DK2155169T3 (en) * 2007-06-08 2016-06-13 Boehringer Ingelheim Int Formulation of nevirapine extended release

Also Published As

Publication number Publication date
EP2822560A1 (en) 2015-01-14
BR112014021927A2 (pt) 2019-09-24
CN104203244A (zh) 2014-12-10
KR20140138837A (ko) 2014-12-04
JP2015509524A (ja) 2015-03-30
WO2013132208A1 (en) 2013-09-12
CA2866133A1 (en) 2013-09-12
IN2014MN01907A (2) 2015-07-10
ZA201406495B (en) 2016-03-30
MX2014010337A (es) 2014-11-14
WO2013132208A8 (en) 2013-11-07
US20150104511A1 (en) 2015-04-16
AU2013229274A1 (en) 2014-09-04

Similar Documents

Publication Publication Date Title
JP7398999B2 (ja) 薬物動態が改善された放出調節ガンマ－ヒドロキシ酪酸塩製剤
Panigrahi et al. Gelucire: A versatile polymer for modified release drug delivery system
CN103917231B (zh) 组蛋白脱乙酰酶抑制剂与苯达莫司汀的联合制剂及其用途
KR101413613B1 (ko) 약 염기성 선택성 세로토닌 5-ｈｔ3 차단제와 유기산을 포함하는 약물 전달 시스템
CN103096881B (zh) 含有具有不愉快味道的药物的膜制剂
RU2616516C2 (ru) Фармацевтическая композиция, содержащая олмесартана медоксомил и розувастатин или его соль
JP2007510656A5 (2)
US20160287525A1 (en) Compositions for colonic delivery of drugs
CN101972236A (zh) 一种含吡非尼酮的缓释制剂
JP2009517466A5 (2)
CA2866133A1 (en) Pharmaceutical antiretroviral combinations comprising lamivudine, festinavir and nevirapine
US20230055404A1 (en) Solid preparation, and preparation method therefor and use thereof
JP2021532193A5 (2)
CN105338970A (zh) 包含他达拉非和坦洛新的药物胶囊复合制剂
KR20130103384A (ko) 클로피도그렐과 아스피린을 포함하는 약학 조성물 및 그의 제조방법
MX2011013091A (es) Un antagonista del receptor de trombina y tableta con dosificacion fija de clopidogrel.
AU2021402764A1 (en) Pharmaceutically stable soft capsule comprising two or more different compositions
JP6236079B2 (ja) ３種の活性成分を含有する新規な時差放出医薬組成物
EP3496719B1 (en) A multi-class anti-retroviral composition
Hadi et al. Novel technologies in formulations: An overview
EP3334419A1 (en) Solid pharmaceutical composition of abacavir, lamivudine, and efavirenz
CN101766608B (zh) 复方盐酸伪麻黄碱缓释制剂及其制备方法
CN101757001B (zh) 一种贝诺酯、伪麻黄碱和氯苯那敏的复方缓释制剂
KR20150105496A (ko) 다폭세틴 및 염산클로미프라민으로부터 선택되는 조루치료제 및 pde5 억제제가 분리된 형태로 존재하는 경구투여 약제학적 제형
CN105326813A (zh) 帕罗西汀缓释组合物及其制备方法

Legal Events

Date Code Title Description
FA92 Acknowledgement of application withdrawn (lack of supplementary materials submitted)

Effective date: 20170615